ExoCoBio
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Website
www.exocobio.comRevenue
$8.5 MillionIndustry
About ExoCoBio
ExoCoBio Org Chart
Is ExoCoBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ExoCoBio launches new products
Congratulate Masked Content for being promoted to Masked Content at ExoCoBio
ExoCoBio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ExoCoBio is spiking on competitors!
Funding: Get notified immidiatlly once ExoCoBio has new funding data
Check if ExoCoBio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ExoCoBio recently announced quarterly report
Click to see if ExoCoBio had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at ExoCoBio
Find 2 more new buyers
Company Profile Activity
Activity Insights
ExoCoBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ExoCoBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ExoCoBio.
ExoCoBio financials insights
Gather financial insights about ExoCoBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$11M
Series B
$26.7M
Series C
$9.3M
ExoCoBio Tech Stack
A closer look at the technologies used by ExoCoBio
ExoCoBio News & Media
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)
- The first plant stem cell-derived exosome patent in the US - The 5th patent allowance following 3 in Korea and 1 in Japan - An important milestone for the global plant stem cell-derived exosome industry SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- ExoCoBio, one of the top three...ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™)
- The first plant stem cell-derived exosome patent in the US - The 5th patent allowance following 3 in Korea and 1 in Japan - An important milestone for the global plant stem cell-derived exosome industry SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- ExoCoBio, one of the top three exosome companies in the world, announced that it has obtained a patent (US Application No: 17/141,693) from the US Patent and Trademark Office for aBENEV Partner ExoCoBio Secures 3 Additional Exosome U.S. Patents
MISSION VIEJO, Calif., March 13, 2023 /PRNewswire/ -- BENEV Company Inc., an FDA registered manufacturer with a global presence, is proud to announce that their strategic partner, ExoCoBio has secured 3 additional patents1 in the U.S. for their Exosome products relating to: The use of...ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA
ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. Cellosome™ HA fillers are expected to be approved in 2023. ExoCoBio has all 3 types of GMP clearance for pharmaceuticals, medical devices, & cosmetics. SEOUL, South Korea, March 2, 2023 /PRNewswire/ --...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ExoCoBio
Founded in 2017 and based out of Seoul, South Korea, ExoCoBio is a developer and manufacturer of exosome-based aesthetic products.... Read More